Burning Rock Biotech Ltd. ADR (BNR): Price and Financial Metrics

Burning Rock Biotech Ltd. ADR (BNR): $2.41

-0.13 (-5.12%)

POWR Rating

Component Grades













BNR Stock Price Chart Interactive Chart >

Price chart for BNR

BNR Price/Volume Stats

Current price $2.41 52-week high $14.00
Prev. close $2.54 52-week low $1.70
Day low $2.35 Volume 184,400
Day high $2.65 Avg. volume 464,265
50-day MA $2.25 Dividend yield N/A
200-day MA $4.14 Market Cap 253.50M

Burning Rock Biotech Ltd. ADR (BNR) Company Bio

Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The company operates through following segment: central laboratory business, in-hospital business and pharma research and development services. Its products and clinical applications including companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. Burning Rock Biotech was founded by Yu Sheng Han in 2014 and is headquartered in Guangzhou, China.

BNR Latest News Stream

Event/Time News Detail
Loading, please wait...

BNR Latest Social Stream

Loading social stream, please wait...

View Full BNR Social Stream

Latest BNR News From Around the Web

Below are the latest news stories about BURNING ROCK BIOTECH LTD that investors may wish to consider to help them evaluate BNR as an investment opportunity.

Burning Rock Biotech Limited Sponsored ADR (BNR) Upgraded to Buy: What Does It Mean for the Stock?

Burning Rock Biotech Limited Sponsored ADR (BNR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | November 21, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic among traders this morning as we cover all of the biggest news moving shares on Wednesday!

William White on InvestorPlace | November 16, 2022

Burning Rock Reports Third Quarter 2022 Financial Results

GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2022. Recent Business Updates Corporate Listed on the Main Market of the London Stock Exchange (the "LSE") by way of a direct listing on November 1, 2022, while Bur

Yahoo | November 16, 2022

Burning Rock Biotech Second Quarter 2022 Earnings: Misses Expectations

Burning Rock Biotech ( NASDAQ:BNR ) Second Quarter 2022 Results Key Financial Results Revenue: CN¥130.8m (up 2.8% from...

Yahoo | November 10, 2022

Admission to Trading on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE UNLAWFUL. BURNING ROCK BIOTECH LIMITED – Admission to Trading on the London Stock Exchange 1 November 2022 Neither this announcement, nor anything contained herein, nor anything contained in the prospectus (the “Prospectus”) referred to herein shall form the basis of, or be relied upon in con

Yahoo | November 1, 2022

Read More 'BNR' Stories Here

BNR Price Returns

1-mo 23.59%
3-mo -24.45%
6-mo 19.90%
1-year -79.88%
3-year N/A
5-year N/A
YTD -74.71%
2021 -58.74%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6028 seconds.